KLS Keeping Law Simple Legislation in plain English

Straight-ahead summaries built from the official bill text. We keep the source links front and center and leave the decision up to you.

Back to Michigan

SB3 • 2026

Health: pharmaceuticals; prescription drug cost and affordability review act; create. Creates new act.

Health: pharmaceuticals; prescription drug cost and affordability review act; create. Creates new act.

Active

The official status still shows this bill as active or still awaiting another formal step.

Sponsor
Darrin Camilleri (District 4), Stephanie Chang (District 3), John Cherry (District 27)
Last action
2025-04-24
Official status
referred to Committee on Government Operations
Effective date
Not listed

Plain English Breakdown

Using official source text because the generated explanation was unavailable or could not be confirmed against the official bill text.

Health: pharmaceuticals; prescription drug cost and affordability review act; create. Creates new act.

Health: pharmaceuticals; prescription drug cost and affordability review act; create.

What This Bill Does

  • Health: pharmaceuticals; prescription drug cost and affordability review act; create.
  • Creates new act.

Limits and Unknowns

  • This entry is temporarily using official source text because the generated explanation could not be confirmed against the official bill text during the last sync.

Amendments

These notes stay tied to the official amendment files and metadata from the legislature.

S-1

4

REPORTED FAVORABLY WITH SUBSTITUTE (S-1) 4/23/2025

Plain English: REPORTED FAVORABLY WITH SUBSTITUTE (S-1) 4/23/2025 4

  • The official amendment file could not be read automatically during the last sync, so only the official amendment metadata is shown right now.

Bill History

  1. 2025-04-24 SJ 36 Pg. 367

    REPORTED FAVORABLY WITH SUBSTITUTE (S-1) 4/23/2025

  2. 2025-04-24 SJ 36 Pg. 367

    REFERRED TO COMMITTEE OF THE WHOLE WITH SUBSTITUTE (S-1)

  3. 2025-04-24 SJ 36 Pg. 354

    RULES SUSPENDED FOR IMMEDIATE CONSIDERATION

  4. 2025-04-24 SJ 36 Pg. 355

    REPORTED BY COMMITTEE OF THE WHOLE FAVORABLY WITH SUBSTITUTE (S-1)

  5. 2025-04-24 SJ 36 Pg. 355

    SUBSTITUTE (S-1) CONCURRED IN

  6. 2025-04-24 SJ 36 Pg. 355

    PLACED ON ORDER OF THIRD READING WITH SUBSTITUTE (S-1)

  7. 2025-04-24 SJ 36 Pg. 355

    RULES SUSPENDED

  8. 2025-04-24 SJ 36 Pg. 355

    PLACED ON IMMEDIATE PASSAGE

  9. 2025-04-24 SJ 36 Pg. 360

    AMENDMENT(S) DEFEATED

  10. 2025-04-24 SJ 36 Pg. 361

    AMENDMENT(S) ADOPTED

  11. 2025-04-24 SJ 36 Pg. 361

    PASSED ROLL CALL # 68 YEAS 20 NAYS 15 EXCUSED 1 NOT VOTING 1

  12. 2025-04-24 HJ 39 Pg. 415

    received on 04/24/2025

  13. 2025-04-24 HJ 39 Pg. 417

    read a first time

  14. 2025-04-24 HJ 39 Pg. 417

    referred to Committee on Government Operations

  15. 2025-01-23 SJ 6 Pg. 47

    SENATE CO-SPONSOR(S) NAMED: STEPHANIE CHANG

  16. 2025-01-08 SJ 1 Pg. 23

    INTRODUCED BY SENATOR DARRIN CAMILLERI

  17. 2025-01-08 SJ 1 Pg. 23

    REFERRED TO COMMITTEE ON FINANCE, INSURANCE, AND CONSUMER PROTECTION

Official Summary Text

Health: pharmaceuticals; prescription drug cost and affordability review act; create. Creates new act.